Literature DB >> 2096279

Cyclosporine therapy in inflammatory bowel disease: open-label experience.

S Lichtiger1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2096279

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN： 0027-2507


× No keyword cloud information.
  4 in total

Review 1.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

Review 2.  Value of colonoscopy for prediction of prognosis in patients with ulcerative colitis.

Authors:  Takafumi Ando; Yuji Nishio; Osamu Watanabe; Hironao Takahashi; Osamu Maeda; Kazuhiro Ishiguro; Daisuke Ishikawa; Naoki Ohmiya; Yasumasa Niwa; Hidemi Goto
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

3.  Perianal Fistulas in Patients With Crohn's Disease, Part 1: Current Medical Management.

Authors:  Stephanie L Gold; Shirley Cohen-Mekelburg; Yecheskel Schneider; Adam Steinlauf
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-08

Review 4.  Cyclosporine and inflammatory bowel disease: buying time.

Authors:  M A Meijssen
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.